Navigation Links
Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit on Tuesday, March 1
Date:3/1/2011

NEW YORK, March 1, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, announced today that Dr. Robert Preti, PhD, President and Chief Scientific Officer of Progenitor Cell Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street, New York, NY. Dr. Preti will present as part of the Adult Stem Cell track at 2:11 pm.

Dr. Preti is co-founder of Progenitor Cell Therapy, LLC, an internationally recognized cell therapy services and development company. Through his administrative duties, Dr. Preti has overseen the growth of PCT from its inception to the world's leading commercial cell therapy company. He is one of the country's leading authorities on cell engineering, advanced cell and gene therapy manufacturing, testing and delivery, and regulatory aspects relating to the cell therapy and regenerative medicine industry and has been a pioneer of cell manufacturing as with Dendreon's product Provenge which just received FDA approval in 2010. He has been the principal investigator for a number of clinical trials relating to the clinical testing of cellular therapies. Previous positions held by Dr. Preti include Scientific and Laboratory Director of Hackensack University Medical Center's stem cell processing and research laboratory and Scientific Director of the Clinical Services Division at the New York Blood Center.

The Company acquired PCT in January 2011. PCT, through its cGMP certified manufacturing facilities and team of professionals, facilitates the preclinical and clinical development and eventual commercialization of cellular therapies for clients in the United States and internationally.

Dr. Robert Pret
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeoStem Acquires Progenitor Cell Therapy
2. NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
3. Progenitor Cell Therapy Expands Manufacturing Operations
4. Progenitor Cell Therapy Appoints VP of Manufacturing Operations
5. NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC
6. Progenitor Cell Therapy Secures Industry Accreditation
7. Reportlinker Adds Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
8. DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients
9. ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
10. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
11. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... WI (PRWEB) January 22, 2015 Dr. Greg ... the 12th annual Scripps Natural Supplements Pre-Conference seminar on probiotics ... Conference is an annual continuing education conference for health care ... and included the topic of probiotics in health. Dr. Leyer ...
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
(Date:12/24/2014)... GMO corn cases filed across the United ... process of being consolidated in a Kansas federal court for ... MIR 162 Corn Litigation, MDL No. 2591 in the U.S. ... the Syngenta GMO corn multidistrict litigation (MDL) has been handed ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... , , Honorees ... to be recognized at Sept. 30 gala ceremony , ... Prix Galien USA will recognize innovative biopharmaceutical drugs and medical technologies ... life at a gala event on September 30. Candidates for the ...
... ALBANY, Ore., Aug. 6 Synthetech, Inc. (OTC Bulletin Board: ... 2010, which ended June 30, 2009. Revenue for the quarter ... million in the first quarter of fiscal 2009. Operating income ... of $314,000 for the same period last year. Net income ...
... , , ST. ... ) today announced the acquisition of cheminformatics company, ChemNavigator(R).com, ... tools used for design, selection and procurement of chemical ... ) comprehensive suite of virtual screening and selection ...
Cached Biology Technology:Prix Galien USA Announces 2009 Final Candidates 2Synthetech Reports First Quarter Fiscal 2010 Results 2Synthetech Reports First Quarter Fiscal 2010 Results 3Synthetech Reports First Quarter Fiscal 2010 Results 4Synthetech Reports First Quarter Fiscal 2010 Results 5Synthetech Reports First Quarter Fiscal 2010 Results 6Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services 2Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services 3
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the leading personal genetics ... fine-scale differences in genetic ancestry of individuals from across ... first arrived more than four hundred years ago, ... place for peoples from different continents. This study illuminates how ...
(Date:12/17/2014)... Dec. 15, 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 Based on ... Samsung introduces for the first time a fingerprint sensor ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... temperatures in the Northeast Shelf Large Marine Ecosystem during ... to the latest Ecosystem Advisory issued by NOAA,s Northeast ... (SSTs) are the latest in a trend of above ... and part of a pattern of elevated temperatures occurring ...
... Proteins, unlike diamonds, aren,t forever. And when they wear ... back into amino acids, where they will be recycled ... Howard Hughes Medical Institute have identified a new way ... of unwanted and potentially toxic proteins, a finding that ...
... , April 26, 2013  Xencor announced today that MorphoSys AG ... trial of MOR208 in B-cell acute lymphoblastic leukemia (B-ALL). MOR208 ... cytotoxic function for which MorphoSys licensed exclusive worldwide rights from ... the study triggers an undisclosed milestone payment to Xencor. ...
Cached Biology News:Sea surface temperatures reach highest level in 150 years 2Sea surface temperatures reach highest level in 150 years 3Scientists discover new way protein degradation is regulated 2Monoclonal Antibody with Xencor's High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia 2
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
... The CHEMICON APO-BRDU Kit is ... DNA breaks and total cellular DNA to ... The kit contains the instructions and reagents ... positive and negative control cells for assessing ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... latest entry in the Biomek line. With an,up-to-date ... robustness, it can meet the needs of just ... either one or two pipetting pods. With its ... standard for flexible laboratory solutions to meet your ...
Biology Products: